id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT02507011
|
5:47:chronic_disease
|
WHO category 1 pulmonary arterial hypertension (Nice 2013)
| 1
|
[
"WHO",
"category",
"1",
"pulmonary",
"arterial",
"hypertension",
"(",
"Nice",
"2013",
")"
] |
[
0,
2,
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02332291
|
8:22:treatment,44:68:treatment,,,114:124:treatment
|
Use of antidepressant medications or other psychotropic medications in the last 4 weeks (or the last 6 weeks for fluoxetine)
| 1
|
[
"Use",
"of",
"antidepressant",
"medications",
"or",
"other",
"psychotropic",
"medications",
"in",
"the",
"last",
"4",
"weeks",
"(",
"or",
"the",
"last",
"6",
"weeks",
"for",
"fluoxetine",
")"
] |
[
0,
0,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT01054196
|
,,,107:116:treatment
|
Men must agree to use a latex condom during sexual contact with a FCBP even if they have had a successful vasectomy
| 1
|
[
"Men",
"must",
"agree",
"to",
"use",
"a",
"latex",
"condom",
"during",
"sexual",
"contact",
"with",
"a",
"FCBP",
"even",
"if",
"they",
"have",
"had",
"a",
"successful",
"vasectomy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02347202
|
76:79:treatment
|
for counselors to be research participants in both the pilot study and the RCT
| 1
|
[
"for",
"counselors",
"to",
"be",
"research",
"participants",
"in",
"both",
"the",
"pilot",
"study",
"and",
"the",
"RCT"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01061515
|
105:117:treatment
|
must undergo a peritoneal scan documenting at least one working intraperitoneal port prior to receiving chemotherapy
| 1
|
[
"must",
"undergo",
"a",
"peritoneal",
"scan",
"documenting",
"at",
"least",
"one",
"working",
"intraperitoneal",
"port",
"prior",
"to",
"receiving",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02165449
|
29:37:treatment
|
Voluntary patient receiving ketamine
| 1
|
[
"Voluntary",
"patient",
"receiving",
"ketamine"
] |
[
0,
0,
0,
1
] |
NCT02272998
|
,35:44:treatment
|
through 4 months after the end of treatment
| 1
|
[
"through",
"4",
"months",
"after",
"the",
"end",
"of",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01877382
|
121:136:treatment,155:171:chronic_disease,213:220:treatment
|
Subject should be able to provide written informed consent, comply with protocol visits and procedures, be able to take oral medication, and not have any active infection or comorbidity that would interfere with therapy
| 1
|
[
"Subject",
"should",
"be",
"able",
"to",
"provide",
"written",
"informed",
"consent",
",",
"comply",
"with",
"protocol",
"visits",
"and",
"procedures",
",",
"be",
"able",
"to",
"take",
"oral",
"medication",
",",
"and",
"not",
"have",
"any",
"active",
"infection",
"or",
"comorbidity",
"that",
"would",
"interfere",
"with",
"therapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1
] |
NCT02100891
|
86:95:treatment
|
Patients, who in the opinion of the investigator, may not be able to comply with the treatment plan or safety monitoring requirements of the study Page 16 of 86 Children's Hospital of Wisconsin Medical College of Wisconsin
| 1
|
[
"Patients",
",",
"who",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
",",
"may",
"not",
"be",
"able",
"to",
"comply",
"with",
"the",
"treatment",
"plan",
"or",
"safety",
"monitoring",
"requirements",
"of",
"the",
"study",
"Page",
"16",
"of",
"86",
"Children",
"'s",
"Hospital",
"of",
"Wisconsin",
"Medical",
"College",
"of",
"Wisconsin"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02122328
|
11:15:chronic_disease
|
Confirmed TTTS patients
| 1
|
[
"Confirmed",
"TTTS",
"patients"
] |
[
0,
2,
0
] |
NCT02161211
|
11:20:treatment
|
inpatient treatment at Lodging Plus primarily for alcohol (vs. other drug) dependence
| 1
|
[
"inpatient",
"treatment",
"at",
"Lodging",
"Plus",
"primarily",
"for",
"alcohol",
"(",
"vs.",
"other",
"drug",
")",
"dependence"
] |
[
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02776761
|
5:42:chronic_disease,54:62:chronic_disease,67:75:chronic_disease
|
Any chronic or active neurologic disorder, including seizures and epilepsy
| 1
|
[
"Any",
"chronic",
"or",
"active",
"neurologic",
"disorder",
",",
"including",
"seizures",
"and",
"epilepsy"
] |
[
0,
2,
2,
2,
2,
2,
0,
0,
2,
0,
2
] |
NCT03179397
|
1:21:chronic_disease
|
Diabetic retinopathy
| 1
|
[
"Diabetic",
"retinopathy"
] |
[
2,
2
] |
NCT02074436
|
1:35:treatment,60:76:chronic_disease,119:123:chronic_disease
|
Hematopoietic stem cell transplant recipients with chronic thrombocytopenia due to chronic graft-versus-host disease (GVHD) or other causes
| 1
|
[
"Hematopoietic",
"stem",
"cell",
"transplant",
"recipients",
"with",
"chronic",
"thrombocytopenia",
"due",
"to",
"chronic",
"graft-versus-host",
"disease",
"(",
"GVHD",
")",
"or",
"other",
"causes"
] |
[
1,
1,
1,
1,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT03068442
|
79:92:chronic_disease,,
|
MRI contraindications per ACR guidelines, including patients with pacemakers, renal failure with eGFR<30 ml/min/1.73m2, and contrast allergy
| 1
|
[
"MRI",
"contraindications",
"per",
"ACR",
"guidelines",
",",
"including",
"patients",
"with",
"pacemakers",
",",
"renal",
"failure",
"with",
"eGFR",
"<",
"30",
"ml/min/1.73m2",
",",
"and",
"contrast",
"allergy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02296684
|
18:29:chronic_disease,42:77:treatment,104:115:chronic_disease,128:135:treatment,163:172:chronic_disease
|
Known history of hepatitis B (defined as hepatitis B survace antigen [HBsAg] reactive) or known active hepatitis C (defined as HCV RNA [qualitative] is detected) infection
| 1
|
[
"Known",
"history",
"of",
"hepatitis",
"B",
"(",
"defined",
"as",
"hepatitis",
"B",
"survace",
"antigen",
"[",
"HBsAg",
"]",
"reactive",
")",
"or",
"known",
"active",
"hepatitis",
"C",
"(",
"defined",
"as",
"HCV",
"RNA",
"[",
"qualitative",
"]",
"is",
"detected",
")",
"infection"
] |
[
0,
0,
0,
2,
2,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
2
] |
NCT02709980
|
1:31:chronic_disease
|
psychiatric comorbid condition
| 1
|
[
"psychiatric",
"comorbid",
"condition"
] |
[
2,
2,
2
] |
NCT02130687
|
24:51:chronic_disease
|
Clinically significant gastrointestinal impairment that could interfere with drug absorption
| 1
|
[
"Clinically",
"significant",
"gastrointestinal",
"impairment",
"that",
"could",
"interfere",
"with",
"drug",
"absorption"
] |
[
0,
0,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02613936
|
5:17:chronic_disease
|
any skull defect
| 1
|
[
"any",
"skull",
"defect"
] |
[
0,
2,
2
] |
NCT01880567
|
1:24:cancer,,
|
Relapsed/refractory MCL: Creatinine (Cr) clearance >= 30 mL/min
| 1
|
[
"Relapsed/refractory",
"MCL",
":",
"Creatinine",
"(",
"Cr",
")",
"clearance",
">",
"=",
"30",
"mL/min"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03113760
|
36:51:treatment
|
Patients receiving stable doses of corticosteroids
| 1
|
[
"Patients",
"receiving",
"stable",
"doses",
"of",
"corticosteroids"
] |
[
0,
0,
0,
0,
0,
1
] |
NCT03008408
|
29:47:treatment,53:68:treatment,80:103:treatment
|
Patients receiving chronic, systemic treatment with corticosteroids or another immunosuppressive agent
| 1
|
[
"Patients",
"receiving",
"chronic",
",",
"systemic",
"treatment",
"with",
"corticosteroids",
"or",
"another",
"immunosuppressive",
"agent"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
1
] |
NCT02925923
|
1:15:treatment
|
Clarithromycin
| 1
|
[
"Clarithromycin"
] |
[
1
] |
NCT02585973
|
1:16:chronic_disease
|
HPV (-) disease
| 1
|
[
"HPV",
"(",
"-",
")",
"disease"
] |
[
2,
2,
2,
0,
0
] |
NCT03006770
|
1:53:chronic_disease
|
acquired immunodeficiency syndrome (AIDS) infections
| 1
|
[
"acquired",
"immunodeficiency",
"syndrome",
"(",
"AIDS",
")",
"infections"
] |
[
2,
2,
2,
2,
2,
0,
0
] |
NCT02272998
|
15:28:chronic_disease,30:52:chronic_disease,56:74:chronic_disease
|
Patients with macular edema, retinal vein occlusion or retinal hemorrhage are excluded
| 1
|
[
"Patients",
"with",
"macular",
"edema",
",",
"retinal",
"vein",
"occlusion",
"or",
"retinal",
"hemorrhage",
"are",
"excluded"
] |
[
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT01367444
|
83:110:treatment,,
|
Enlargement in the area of central macular retinal thinning/photoreceptor loss by ocular coherence tomography at a rate of ≥0.5 mm^2
| 1
|
[
"Enlargement",
"in",
"the",
"area",
"of",
"central",
"macular",
"retinal",
"thinning/photoreceptor",
"loss",
"by",
"ocular",
"coherence",
"tomography",
"at",
"a",
"rate",
"of",
"≥0.5",
"mm^2"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02372006
|
14:17:cancer,19:23:cancer,25:46:cancer,48:63:cancer,64:68:cancer,70:80:cancer,82:95:cancer,97:100:cancer,105:112:cancer
|
diagnosis of HGG, DIPG, low grade astrocytoma, medulloblastoma/PNET, ependymoma, neuroblastoma, RMS and tumours with ErbB deregulation
| 1
|
[
"diagnosis",
"of",
"HGG",
",",
"DIPG",
",",
"low",
"grade",
"astrocytoma",
",",
"medulloblastoma/PNET",
",",
"ependymoma",
",",
"neuroblastoma",
",",
"RMS",
"and",
"tumours",
"with",
"ErbB",
"deregulation"
] |
[
0,
0,
3,
0,
3,
0,
3,
3,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
0,
0
] |
NCT02650206
|
7:24:treatment
|
Prior Bariatric surgery
| 1
|
[
"Prior",
"Bariatric",
"surgery"
] |
[
0,
1,
1
] |
NCT02860000
|
66:79:cancer
|
Histologic proof of metastatic or locally advanced, unresectable breast cancer
| 1
|
[
"Histologic",
"proof",
"of",
"metastatic",
"or",
"locally",
"advanced",
",",
"unresectable",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02549833
|
17:35:chronic_disease
|
Must be free of systemic infection
| 1
|
[
"Must",
"be",
"free",
"of",
"systemic",
"infection"
] |
[
0,
0,
0,
0,
2,
2
] |
NCT02085941
|
1:7:cancer,37:40:treatment,56:59:treatment,60:62:treatment
|
Tumors that are not clearly seen by MRI but showing on PET/CT will be ablated with PET/CT guidance
| 1
|
[
"Tumors",
"that",
"are",
"not",
"clearly",
"seen",
"by",
"MRI",
"but",
"showing",
"on",
"PET/CT",
"will",
"be",
"ablated",
"with",
"PET/CT",
"guidance"
] |
[
3,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02519543
|
1:6:chronic_disease
|
mania
| 1
|
[
"mania"
] |
[
2
] |
NCT02481310
|
57:67:cancer,
|
Patients who have been diagnosed or treated for another malignancy within 2 years before study enrollment
| 1
|
[
"Patients",
"who",
"have",
"been",
"diagnosed",
"or",
"treated",
"for",
"another",
"malignancy",
"within",
"2",
"years",
"before",
"study",
"enrollment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0
] |
NCT00734877
|
24:34:cancer,38:63:cancer,57:63:cancer,68:88:cancer,
|
for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease free for at least three years
| 1
|
[
"for",
"adequately",
"treated",
"basal",
"cell",
"or",
"squamous",
"cell",
"skin",
"cancer",
",",
"in",
"situ",
"cervical",
"cancer",
",",
"or",
"other",
"cancer",
"for",
"which",
"the",
"patient",
"has",
"been",
"disease",
"free",
"for",
"at",
"least",
"three",
"years"
] |
[
0,
0,
0,
3,
3,
0,
3,
3,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02048371
|
82:93:cancer,95:113:chronic_disease,115:120:cancer,121:139:cancer,180:205:cancer,209:235:cancer
|
Patients must have histologically or cytologically confirmed advanced/metastatic liposarcoma, osteogenic sarcoma, Ewing/Ewing-like sarcoma of soft tissue or bone, fusion-positive alveolar rhabdomyosarcoma or embryonal rhabdomyosarcoma/fusion-negative alveolar rhabdomyosarcoma
| 1
|
[
"Patients",
"must",
"have",
"histologically",
"or",
"cytologically",
"confirmed",
"advanced/metastatic",
"liposarcoma",
",",
"osteogenic",
"sarcoma",
",",
"Ewing/Ewing-like",
"sarcoma",
"of",
"soft",
"tissue",
"or",
"bone",
",",
"fusion-positive",
"alveolar",
"rhabdomyosarcoma",
"or",
"embryonal",
"rhabdomyosarcoma/fusion-negative",
"alveolar",
"rhabdomyosarcoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
2,
2,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
0,
0
] |
NCT02273362
|
1:13:treatment,17:36:treatment,40:55:chronic_disease,,81:96:treatment,98:113:treatment
|
Percutaneous or transjugular biopsy of cirrhotic liver at least 7 days prior to liver resection (surgical cohort)
| 1
|
[
"Percutaneous",
"or",
"transjugular",
"biopsy",
"of",
"cirrhotic",
"liver",
"at",
"least",
"7",
"days",
"prior",
"to",
"liver",
"resection",
"(",
"surgical",
"cohort",
")"
] |
[
1,
0,
1,
1,
0,
2,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT01954173
|
1:43:chronic_disease
|
Acquired immune deficiency syndrome (AIDS)
| 1
|
[
"Acquired",
"immune",
"deficiency",
"syndrome",
"(",
"AIDS",
")"
] |
[
2,
2,
2,
2,
2,
0,
0
] |
NCT02236000
|
1:23:chronic_disease
|
Malabsorption syndrome
| 1
|
[
"Malabsorption",
"syndrome"
] |
[
2,
2
] |
NCT02688647
|
1:18:treatment,22:37:treatment,48:64:treatment,69:81:treatment
|
Immunosuppressive or cytotoxic drugs including cyclophosphamide and azathioprine
| 1
|
[
"Immunosuppressive",
"or",
"cytotoxic",
"drugs",
"including",
"cyclophosphamide",
"and",
"azathioprine"
] |
[
1,
0,
1,
1,
0,
1,
0,
1
] |
NCT01626079
|
,,65:99:treatment,
|
Mitral valve orifice area < 4.0 cm2 assessed by site based on a transthoracic echocardiogram (TTE) within 90 days prior to subject registration
| 1
|
[
"Mitral",
"valve",
"orifice",
"area",
"<",
"4.0",
"cm2",
"assessed",
"by",
"site",
"based",
"on",
"a",
"transthoracic",
"echocardiogram",
"(",
"TTE",
")",
"within",
"90",
"days",
"prior",
"to",
"subject",
"registration"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02865135
|
1:10:chronic_disease
|
dysphagia
| 1
|
[
"dysphagia"
] |
[
2
] |
NCT02594111
|
1:11:treatment,
|
Colchicine use within 1 month
| 1
|
[
"Colchicine",
"use",
"within",
"1",
"month"
] |
[
1,
0,
0,
0,
0
] |
NCT02050113
|
1:27:chronic_disease
|
Uncorrectable coagulopathy
| 1
|
[
"Uncorrectable",
"coagulopathy"
] |
[
2,
2
] |
NCT01508390
|
4:17:treatment
|
No aneurysm clip in the brain
| 1
|
[
"No",
"aneurysm",
"clip",
"in",
"the",
"brain"
] |
[
0,
1,
1,
0,
0,
0
] |
NCT02663934
|
1:18:chronic_disease
|
pulmonary disease that precludes ability to safely exercise
| 1
|
[
"pulmonary",
"disease",
"that",
"precludes",
"ability",
"to",
"safely",
"exercise"
] |
[
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT01526603
|
40:52:treatment
|
Recovery from last induction course of chemotherapy
| 1
|
[
"Recovery",
"from",
"last",
"induction",
"course",
"of",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02323191
|
12:46:chronic_disease
|
History of human immunodeficiency virus (HIV)
| 1
|
[
"History",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")"
] |
[
0,
0,
2,
2,
2,
2,
0,
0
] |
NCT02543983
|
130:138:allergy_name
|
A medical finding or condition that in the clinical judgement of the investigator increases the risk of adverse effects from the ketamine administration (for example: findings suggesting difficulties with kidney or cardiac function that may be contradictions for an experimental intervention)
| 1
|
[
"A",
"medical",
"finding",
"or",
"condition",
"that",
"in",
"the",
"clinical",
"judgement",
"of",
"the",
"investigator",
"increases",
"the",
"risk",
"of",
"adverse",
"effects",
"from",
"the",
"ketamine",
"administration",
"(",
"for",
"example",
":",
"findings",
"suggesting",
"difficulties",
"with",
"kidney",
"or",
"cardiac",
"function",
"that",
"may",
"be",
"contradictions",
"for",
"an",
"experimental",
"intervention",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02130388
|
1:13:treatment,,,
|
Chemotherapy within past 4 weeks or Absolute Neutrophil Count<500
| 1
|
[
"Chemotherapy",
"within",
"past",
"4",
"weeks",
"or",
"Absolute",
"Neutrophil",
"Count",
"<",
"500"
] |
[
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01042522
|
58:76:allergy_name,103:109:cancer,212:223:chronic_disease,240:255:treatment
|
Patients with a history of hypersensitivity reactions to prior chemotherapy administered for previous cancer diagnoses are eligible to participate in the study, unless the hypersensitivity reaction consisted of anaphylaxis not amenable to desensitization
| 1
|
[
"Patients",
"with",
"a",
"history",
"of",
"hypersensitivity",
"reactions",
"to",
"prior",
"chemotherapy",
"administered",
"for",
"previous",
"cancer",
"diagnoses",
"are",
"eligible",
"to",
"participate",
"in",
"the",
"study",
",",
"unless",
"the",
"hypersensitivity",
"reaction",
"consisted",
"of",
"anaphylaxis",
"not",
"amenable",
"to",
"desensitization"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
1
] |
NCT02367040
|
1:32:cancer,,
|
Small lymphocytic lymphoma(SLL) with absolute lymphocyte count <5x10*9/L at study entry
| 1
|
[
"Small",
"lymphocytic",
"lymphoma",
"(",
"SLL",
")",
"with",
"absolute",
"lymphocyte",
"count",
"<",
"5x10",
"*",
"9/L",
"at",
"study",
"entry"
] |
[
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02195232
|
1:28:chronic_disease
|
Familial bleeding diathesis
| 1
|
[
"Familial",
"bleeding",
"diathesis"
] |
[
2,
2,
2
] |
NCT02645539
|
,25:34:treatment
|
Receiving more than two inotropes
| 1
|
[
"Receiving",
"more",
"than",
"two",
"inotropes"
] |
[
0,
0,
0,
0,
1
] |
NCT00924027
|
36:43:treatment,58:67:treatment,86:109:cancer
|
Patients who are unable to undergo surgery and must have treatment for an inoperable primary cervical cancer
| 1
|
[
"Patients",
"who",
"are",
"unable",
"to",
"undergo",
"surgery",
"and",
"must",
"have",
"treatment",
"for",
"an",
"inoperable",
"primary",
"cervical",
"cancer"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
3,
3,
3
] |
NCT01968590
|
1:23:treatment,
|
bisphosphonate therapy for more than 3 months
| 1
|
[
"bisphosphonate",
"therapy",
"for",
"more",
"than",
"3",
"months"
] |
[
1,
1,
0,
0,
0,
0,
0
] |
NCT02496663
|
,,,112:121:treatment
|
Women of childbearing potential must have a negative urine pregnancy test within 7 days prior to initiation of treatment
| 1
|
[
"Women",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"negative",
"urine",
"pregnancy",
"test",
"within",
"7",
"days",
"prior",
"to",
"initiation",
"of",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02073097
|
16:27:treatment,99:122:treatment,,,,,,,339:348:treatment,,,,,,,699:710:treatment
|
The effects of Carfilzomib on the developing human fetus are unknown. For this reason and because chemotherapeutic agents used in this study are known to be teratogenic, women of child-bearing potential and men must agree to use adequate contraception (double barrier method of birth control or abstinence) 2 weeks prior to initiation of treatment, for the duration of study participation and for 3 months after completing treatment. Should a woman become pregnant or suspect that she is pregnant while she or her partner is participating in this study, she should inform the treating physician immediately. Men must agree to refrain from sperm donation for at least 90 days after the last dose of carfilzomib
| 1
|
[
"The",
"effects",
"of",
"Carfilzomib",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown",
".",
"For",
"this",
"reason",
"and",
"because",
"chemotherapeutic",
"agents",
"used",
"in",
"this",
"study",
"are",
"known",
"to",
"be",
"teratogenic",
",",
"women",
"of",
"child-bearing",
"potential",
"and",
"men",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"(",
"double",
"barrier",
"method",
"of",
"birth",
"control",
"or",
"abstinence",
")",
"2",
"weeks",
"prior",
"to",
"initiation",
"of",
"treatment",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
"and",
"for",
"3",
"months",
"after",
"completing",
"treatment",
".",
"Should",
"a",
"woman",
"become",
"pregnant",
"or",
"suspect",
"that",
"she",
"is",
"pregnant",
"while",
"she",
"or",
"her",
"partner",
"is",
"participating",
"in",
"this",
"study",
",",
"she",
"should",
"inform",
"the",
"treating",
"physician",
"immediately",
".",
"Men",
"must",
"agree",
"to",
"refrain",
"from",
"sperm",
"donation",
"for",
"at",
"least",
"90",
"days",
"after",
"the",
"last",
"dose",
"of",
"carfilzomib"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02138669
|
1:18:chronic_disease
|
corneal dystrophy
| 1
|
[
"corneal",
"dystrophy"
] |
[
2,
2
] |
NCT01659203
|
1:13:treatment,
|
Chemotherapy within 4 weeks prior to entering study
| 1
|
[
"Chemotherapy",
"within",
"4",
"weeks",
"prior",
"to",
"entering",
"study"
] |
[
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02416206
|
,43:55:treatment
|
Within 9 months of the start of induction chemotherapy and no evidence of relapse or progression
| 1
|
[
"Within",
"9",
"months",
"of",
"the",
"start",
"of",
"induction",
"chemotherapy",
"and",
"no",
"evidence",
"of",
"relapse",
"or",
"progression"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02327312
|
1:20:chronic_disease
|
Open angle Glaucoma
| 1
|
[
"Open",
"angle",
"Glaucoma"
] |
[
2,
2,
2
] |
NCT02389023
|
27:33:allergy_name
|
Sensitivity or allergy to silver
| 1
|
[
"Sensitivity",
"or",
"allergy",
"to",
"silver"
] |
[
0,
0,
0,
0,
4
] |
NCT02799095
|
59:68:allergy_name
|
Subjects with known hypersensitivity to any components of ALKS 4230
| 1
|
[
"Subjects",
"with",
"known",
"hypersensitivity",
"to",
"any",
"components",
"of",
"ALKS",
"4230"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
4,
4
] |
NCT01620216
|
4:27:chronic_disease
|
No uncontrolled infections as determined by the investigator
| 1
|
[
"No",
"uncontrolled",
"infections",
"as",
"determined",
"by",
"the",
"investigator"
] |
[
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02409888
|
29:38:treatment
|
mandated to substance abuse treatment by a court order
| 1
|
[
"mandated",
"to",
"substance",
"abuse",
"treatment",
"by",
"a",
"court",
"order"
] |
[
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT00862433
|
18:21:allergy_name,25:28:allergy_name,30:51:allergy_name,56:61:allergy_name,62:68:allergy_name
|
Food allergy, to soy or egg, milk protein (casein), or wheat/gluten
| 1
|
[
"Food",
"allergy",
",",
"to",
"soy",
"or",
"egg",
",",
"milk",
"protein",
"(",
"casein",
")",
",",
"or",
"wheat/gluten"
] |
[
0,
0,
0,
0,
4,
0,
4,
0,
4,
4,
4,
0,
0,
0,
0,
4
] |
NCT01940822
|
18:26:allergy_name
|
Prior history of caffeine sensitivity or allergy
| 1
|
[
"Prior",
"history",
"of",
"caffeine",
"sensitivity",
"or",
"allergy"
] |
[
0,
0,
0,
4,
0,
0,
0
] |
NCT00737399
|
14:32:cancer
|
Diagnosis of cholangiocarcinoma
| 1
|
[
"Diagnosis",
"of",
"cholangiocarcinoma"
] |
[
0,
0,
3
] |
NCT02329652
|
8:31:chronic_disease
|
severe cardiopulmonary disease
| 1
|
[
"severe",
"cardiopulmonary",
"disease"
] |
[
0,
2,
2
] |
NCT02319369
|
8:30:chronic_disease,41:55:treatment,57:67:treatment,72:83:treatment,91:129:chronic_disease,141:167:chronic_disease
|
Has an uncontrolled infection requiring IV antibiotics, antivirals, or antifungals, known human immunodeficiency virus infection, or active hepatitis B or C infection
| 1
|
[
"Has",
"an",
"uncontrolled",
"infection",
"requiring",
"IV",
"antibiotics",
",",
"antivirals",
",",
"or",
"antifungals",
",",
"known",
"human",
"immunodeficiency",
"virus",
"infection",
",",
"or",
"active",
"hepatitis",
"B",
"or",
"C",
"infection"
] |
[
0,
0,
2,
2,
0,
1,
1,
0,
1,
0,
0,
1,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
2
] |
NCT02115295
|
74:86:treatment
|
Patient with documented hypersensitivity to any of the components of the chemotherapy program
| 1
|
[
"Patient",
"with",
"documented",
"hypersensitivity",
"to",
"any",
"of",
"the",
"components",
"of",
"the",
"chemotherapy",
"program"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02706353
|
,106:121:treatment,123:125:treatment,129:132:treatment,160:169:chronic_disease,171:183:treatment,185:190:chronic_disease,,
|
At least two injectable lesions (amenable for direct injection or through the use of image guidance such ultrasound [US], CT or MRI) defined as any injectable cutaneous, subcutaneous, nodal, or visceral melanoma lesion >/= 10 mm in longest diameter
| 1
|
[
"At",
"least",
"two",
"injectable",
"lesions",
"(",
"amenable",
"for",
"direct",
"injection",
"or",
"through",
"the",
"use",
"of",
"image",
"guidance",
"such",
"ultrasound",
"[",
"US",
"]",
",",
"CT",
"or",
"MRI",
")",
"defined",
"as",
"any",
"injectable",
"cutaneous",
",",
"subcutaneous",
",",
"nodal",
",",
"or",
"visceral",
"melanoma",
"lesion",
">",
"/=",
"10",
"mm",
"in",
"longest",
"diameter"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
2,
0,
1,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02272218
|
40:55:treatment,
|
any clinical disorder requiring use of corticosteroids within one week of visit
| 1
|
[
"any",
"clinical",
"disorder",
"requiring",
"use",
"of",
"corticosteroids",
"within",
"one",
"week",
"of",
"visit"
] |
[
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02519322
|
,,,55:64:treatment
|
Hemoglobin >= 8.5 g/dL (within 28 days of first study treatment)
| 1
|
[
"Hemoglobin",
">",
"=",
"8.5",
"g/dL",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT02321501
|
22:30:treatment,22:48:treatment,79:93:treatment,95:109:treatment,153:163:treatment,165:176:treatment,178:186:treatment
|
Therapeutic doses of warfarin sodium (Coumadin) or any other coumadin-derived anti-coagulant. Anticoagulants not derived from warfarin are allowed (eg, dabigatran, rivaroxaban, apixaban)
| 1
|
[
"Therapeutic",
"doses",
"of",
"warfarin",
"sodium",
"(",
"Coumadin",
")",
"or",
"any",
"other",
"coumadin-derived",
"anti-coagulant",
".",
"Anticoagulants",
"not",
"derived",
"from",
"warfarin",
"are",
"allowed",
"(",
"eg",
",",
"dabigatran",
",",
"rivaroxaban",
",",
"apixaban",
")"
] |
[
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0
] |
NCT02101736
|
18:32:treatment
|
Subject requires anticoagulants
| 1
|
[
"Subject",
"requires",
"anticoagulants"
] |
[
0,
0,
1
] |
NCT02154568
|
1:18:chronic_disease
|
Pulmonary Disease Subjects
| 1
|
[
"Pulmonary",
"Disease",
"Subjects"
] |
[
2,
2,
0
] |
NCT01061515
|
30:47:treatment,53:66:treatment,,136:148:treatment
|
Patients must have undergone debulking surgery with peritonectomy and have been allowed at least 4 weeks to recover prior to receiving chemotherapy
| 1
|
[
"Patients",
"must",
"have",
"undergone",
"debulking",
"surgery",
"with",
"peritonectomy",
"and",
"have",
"been",
"allowed",
"at",
"least",
"4",
"weeks",
"to",
"recover",
"prior",
"to",
"receiving",
"chemotherapy"
] |
[
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02780401
|
18:62:chronic_disease
|
Known history of human immunodeficiency virus (HIV) infection
| 1
|
[
"Known",
"history",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"infection"
] |
[
0,
0,
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT02536794
|
,27:43:cancer
|
#ERROR!
| 1
|
[
"#",
"ERROR",
"!"
] |
[
0,
3,
0
] |
NCT00734877
|
10:20:cancer
|
No prior malignancy is allowed
| 1
|
[
"No",
"prior",
"malignancy",
"is",
"allowed"
] |
[
0,
0,
3,
0,
0
] |
NCT01505569
|
1:12:chronic_disease,,,,
|
Hematologic: hemoglobin of >9 gm/dl and platelet count > 20,000/μl
| 1
|
[
"Hematologic",
":",
"hemoglobin",
"of",
">",
"9",
"gm/dl",
"and",
"platelet",
"count",
">",
"20,000/μl"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02846532
|
44:70:chronic_disease
|
History of or signs/symptoms suggestive of protein-losing enteropathy
| 1
|
[
"History",
"of",
"or",
"signs/symptoms",
"suggestive",
"of",
"protein-losing",
"enteropathy"
] |
[
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01037790
|
,,80:98:treatment,
|
Females of childbearing potential are defined as sexually mature women without prior hysterectomy or who have had any evidence of menses in the past 12 months
| 1
|
[
"Females",
"of",
"childbearing",
"potential",
"are",
"defined",
"as",
"sexually",
"mature",
"women",
"without",
"prior",
"hysterectomy",
"or",
"who",
"have",
"had",
"any",
"evidence",
"of",
"menses",
"in",
"the",
"past",
"12",
"months"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02219581
|
38:45:treatment
|
Patients that have an intolerance to Toradol
| 1
|
[
"Patients",
"that",
"have",
"an",
"intolerance",
"to",
"Toradol"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT02407171
|
,126:135:treatment
|
Demonstrate adequate organ function as defined in Table 1, all screening labs should be performed within 28 days of protocol treatment
| 1
|
[
"Demonstrate",
"adequate",
"organ",
"function",
"as",
"defined",
"in",
"Table",
"1",
",",
"all",
"screening",
"labs",
"should",
"be",
"performed",
"within",
"28",
"days",
"of",
"protocol",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02481245
|
24:33:treatment
|
History of significant treatment non-adherence or situations where the subjects is unlikely to adhere to treatment, in the opinion of the investigator
| 1
|
[
"History",
"of",
"significant",
"treatment",
"non-adherence",
"or",
"situations",
"where",
"the",
"subjects",
"is",
"unlikely",
"to",
"adhere",
"to",
"treatment",
",",
"in",
"the",
"opinion",
"of",
"the",
"investigator"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02628535
|
8:13:chronic_disease,15:24:chronic_disease,29:54:chronic_disease,65:85:treatment,
|
Active viral, bacterial, or systemic fungal infection requiring parenteral treatment within 7 days of first study drug administration
| 1
|
[
"Active",
"viral",
",",
"bacterial",
",",
"or",
"systemic",
"fungal",
"infection",
"requiring",
"parenteral",
"treatment",
"within",
"7",
"days",
"of",
"first",
"study",
"drug",
"administration"
] |
[
0,
2,
0,
2,
0,
0,
2,
2,
2,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01697293
|
,39:55:treatment,61:72:treatment,77:94:treatment,,111:123:treatment,134:144:treatment
|
at least 3 weeks for the last dose of biologic therapy (eg, bevacizumab) or cytotoxic therapy (or 2 weeks for capecitabine or weekly paclitaxel
| 1
|
[
"at",
"least",
"3",
"weeks",
"for",
"the",
"last",
"dose",
"of",
"biologic",
"therapy",
"(",
"eg",
",",
"bevacizumab",
")",
"or",
"cytotoxic",
"therapy",
"(",
"or",
"2",
"weeks",
"for",
"capecitabine",
"or",
"weekly",
"paclitaxel"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
0,
1
] |
NCT02148796
|
21:38:chronic_disease
|
Physician-diagnosed atopic dermatitis in the participant
| 1
|
[
"Physician-diagnosed",
"atopic",
"dermatitis",
"in",
"the",
"participant"
] |
[
0,
2,
2,
0,
0,
0
] |
NCT02658565
|
23:35:treatment
|
Patients who received chemotherapy directed at the present disease
| 1
|
[
"Patients",
"who",
"received",
"chemotherapy",
"directed",
"at",
"the",
"present",
"disease"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02527421
|
12:28:treatment,39:56:treatment,58:61:chronic_disease
|
History of organ transplant requiring immunosuppression, HIV, or other immunocompromised state
| 1
|
[
"History",
"of",
"organ",
"transplant",
"requiring",
"immunosuppression",
",",
"HIV",
",",
"or",
"other",
"immunocompromised",
"state"
] |
[
0,
0,
1,
1,
0,
1,
0,
2,
0,
0,
0,
0,
0
] |
NCT02579174
|
60:71:treatment
|
Ligamentous instability that may necessitate a constrained TKR implant
| 1
|
[
"Ligamentous",
"instability",
"that",
"may",
"necessitate",
"a",
"constrained",
"TKR",
"implant"
] |
[
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02343042
|
23:38:treatment
|
Patients on long-term glucocorticoids during Screening do not require a washout period
| 1
|
[
"Patients",
"on",
"long-term",
"glucocorticoids",
"during",
"Screening",
"do",
"not",
"require",
"a",
"washout",
"period"
] |
[
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02907944
|
1:4:chronic_disease
|
HIV-infected
| 1
|
[
"HIV-infected"
] |
[
2
] |
NCT02393885
|
1:24:chronic_disease
|
Refractory hypertension
| 1
|
[
"Refractory",
"hypertension"
] |
[
2,
2
] |
NCT02278315
|
1:35:treatment
|
Serum free light chain (FLC) assay
| 1
|
[
"Serum",
"free",
"light",
"chain",
"(",
"FLC",
")",
"assay"
] |
[
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT02556606
|
56:92:treatment,96:119:treatment,127:135:treatment,137:147:treatment,149:160:treatment,162:171:treatment,173:183:treatment,185:201:treatment,203:216:treatment,226:243:treatment
|
Patients taking medications with known activity at the N-methyl-D-aspartate receptor (NMDA) or AMPA glutamate receptor [e.g., riluzole, amantadine, lamotrigine, memantine, topiramate, dextromethorphan, D-cycloserine], or the muopioid receptor
| 1
|
[
"Patients",
"taking",
"medications",
"with",
"known",
"activity",
"at",
"the",
"N-methyl-D-aspartate",
"receptor",
"(",
"NMDA",
")",
"or",
"AMPA",
"glutamate",
"receptor",
"[",
"e.g.",
",",
"riluzole",
",",
"amantadine",
",",
"lamotrigine",
",",
"memantine",
",",
"topiramate",
",",
"dextromethorphan",
",",
"D-cycloserine",
"]",
",",
"or",
"the",
"muopioid",
"receptor"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
0,
0,
0,
1,
1
] |
NCT00670358
|
4:55:chronic_disease
|
No post-transplant lymphoproliferative disorder (PTLD)
| 1
|
[
"No",
"post-transplant",
"lymphoproliferative",
"disorder",
"(",
"PTLD",
")"
] |
[
0,
2,
2,
2,
2,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.